Latest Headaches Stories
SCHOFIELD, Wis., May 23, 2013 /PRNewswire/ -- PuraMed BioScience(®), Inc., (OTCBB: PMBS) a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced that Ludlow Research re-issued its research opinion on the company based on low market capitalization valuation. Report Highlights Non-Prescription, All Natural Product to Treat Migraine Headaches Clinical Trials Show the Product Outperforms #1 Prescription Competitor Currently...
Older people with a history of migraines and depression may have smaller brain tissue volumes than people with only one or neither of the conditions, according to a new study in the May 22, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. "Studies show that people with migraine have double the risk of depression compared to people without migraine," said study author Larus S. Gudmundsson, PhD, with the National Institute on Aging and the...
TV Show To Feature PILLO1, Only Pillow In The World Designed By A Doctor, Guaranteed To Relieve Neck Pain While You Sleep. LOS ANGELES, May 22, 2013 /PRNewswire/ -- PILLO1, a doctor invented sleep device designed to reduce neck pain and improve sleep quality, today announced that its inventor, Dr. Raymond Hall, DC, will be featured on the syndicated television talk show, The Doctors, on May 23, 2013 (check local listings). The show will air on local affiliates in the U.S. and Canada....
SCHOFIELD, Wis., May 21, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced the results of clinical trials that found its over-the-counter migraine medication product, LipiGesic(®) M, has "robust efficacy". With recent statistics showing nearly 39 million Americans suffering from migraine headaches, studies show that LipiGesic M provides a safe, highly effective...
SCHOFIELD, Wis., May 15, 2013 /PRNewswire/ -- PuraMed BioScience(®), Inc., (OTCBB: PMBS) announces the launch of its Business-to-Business Migraine First Aid Kit((TM)). The program, which is available to businesses of any size, can help migraine sufferers stay on the job and stay productive by eliminating migraine pain and associated symptoms. "Knowing that migraines are debilitating for many people we looked at their impact on the business sector," said Charles Phillips, board...
Metadrin, an all natural, herbal supplement developed for the treatment of migraines is proud to share the release of their new product and website. Cedartown, GA (PRWEB) May 14, 2013 Metadrin, an all natural, herbal supplement developed for the treatment of migraines is proud to share the release of their new product and website at http://metadrin.com. More than 28 million people in the United States have migraines. Most often seen in adults ages 25 through 55, women are nearly 3 times...
SCHOFIELD, Wis., May 13, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (PMBS: OTCBB), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announces the receipt of its first International order for LipiGesic® M its non-drowsy, clinically tested, over-the-counter migraine relief product. Through an agreement with Biokemical, PuraMed BioScience has now expanded international distribution of LipiGesic M to Columbia, South America....
World-renowned dermatologists at Goldman, Butterwick, Fitzpatrick, Groff & Fabi Cosmetic Laser Dermatology center respond to recent reports suggesting an improved success of using Botox to combat an aching head. San Diego, California (PRWEB) May 08, 2013 According to recent reports and additional testing, Botox injections continue to prove safe and effective for the treatment of migraines and tension headaches. At the highly-respected center of Goldman, Butterwick, Fitzpatrick, Groff...
Chief Scientist Participates in Clinical and Basic Science Data Blitz MORAGA, Calif., May 9, 2013 /PRNewswire/ -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, announced that David C. Yeomans, Ph.D., Chief Scientist and Founder, as well as the Director of Pain Research at Stanford University School of Medicine, gave a presentation at the American Pain Society (APS) 32(nd) Annual...
New Non-Oral Triptans and Non-Triptan Products Will Provide Acute Treatment Alternatives for Oral Triptan Non-Responders, According to a New Report from Decision Resources BURLINGTON, Mass., May 8, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed neurologists and primary care physicians (PCPs) expect to more than double their use of Allergan's prophylactic migraine treatment...
Latest Headaches Reference Libraries
Heat therapy is a treatment in the medical field to relieve pain and improve over health. It can be a therapy used only once, repeatedly in rehabilitation sessions, or as part of an after-care routine in sports medicine. It can be delivered in many forms with success in all. How the Heat Helps As heat is introduced to the area, the temperature will increase beginning from the outer layer and moving deeper into the tissues. After the change in temperature, the blood vessels in the area of...
Cephalalgia is a peer-reviewed medical journal published by SAGE Publications on behalf of the International Headache Society. The journal is subtitled 'An International Journal of Headache'. The journal was established in 1981 and is published tri-weekly (or 16 times per year). It was previously published by Blackwell Publishing. The editor-in-chief is David W. Dodick of Mayo Clinic College of Medicine. Cephalalgia provides an international forum for research, review and discussions on...
